Statistics from Altmetric.com
Abnormal protein deposits are observed in the cytoplasm of sporadic inclusion body myositis (s-IBM) muscle. A number of proteins known to be included in s-IBM aggregates have also been described in various neurodegenerative diseases, including ubiquitin, β amyloid peptide, α-synuclein, phosphorylated τ and TAR DNA-binding protein (TDP-43).
In the central nervous system (CNS), TDP-43 aggregates are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive neuronal inclusions. Numerous dominant mutations in the TARDBP gene encoding TDP-43 protein have been reported in ALS cases, demonstrating that TDP-43 abnormalities could directly trigger neurodegeneration. The recent discovery of mutations in the gene encoding Fused in Sarcoma (FUS) protein, which shares functional and structural homology with TDP-43, has strengthened the prominence of gene expression-mediating proteins in ALS pathogenesis. Whether muscle TDP-43 aggregates observed in s-IBM are just trashed protein, or whether they are pathogenic, particularly trough RNA metabolism disturbances, remains unknown.
We hypothesised that FUS protein could be altered in TDP-43 positive muscles of s-IBM. For this purpose, we investigated the protein muscle expression of TDP-43 and FUS in s-IBM compared to sporadic amyotrophic lateral sclerosis (SALS) patients (including one patient with TARDBP gene mutation) and controls. We report abnormal FUS and TDP-43 fragments in s-IBM and TARDBP-linked disease.
Five patients with s-IBM, five patients with …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.